CD8A and neoplasm: Ex vivo analysis of CD8+ tumor-infiltrating lymphocytes (TILs) showed that the ability of CD8+ TILs to produce IFN-γ following stimulation with PMA/ionomycin was significantly enhanced by rapamycin in combination with anti-PD-L1 mAb compared to monotherapies.